Lixia Ding

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

Benshang Li, Samuel W. Brady, Xiaotu Ma et al. · Blood · 2019 · 286 citations · Full text

Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL

Benshang Li, Hui Li, Yun Bai et al. · Nature Medicine · 2015 · 172 citations · Full text

Molecular Physiology, Signal Transduction, Genetics +4

Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial

Tianyi Wang, Yanjing Tang, Jiaoyang Cai et al. · Journal of Clinical Oncology · 2022 · 87 citations · Full text

Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse

Fan Yang, Samuel W. Brady, Chao Tang et al. · Nature Cancer · 2021 · 46 citations

Genome Instability, Somatic Variant, Medicine +8

Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia

Yali Chen, Chao Tang, Meng‐Yi Zhang et al. · Leukemia · 2019 · 35 citations

Hematological Malignancy, Tumor Biology, Chemotherapy Response +11